ABSTRACT
Background We aimed to investigate the association between long-term adherence to MedDiet and LTPA levels and the initiation of antidepressant, anxiolytic, antipsychotic and antiseizure medication in older adults.
Methods. We assessed the relationship between the cumulative average of MedDiet adherence and LTPA and the initiation of medications in the PREvención con DIeta MEDiterránea (PREDIMED) study. Sample sizes ranged from 5,940 for anxiolytics to 6,896 for antipsychotics. Associations between the cumulative average of MedDiet adherence (per each one-point increase in the adherence score) and LTPA (per each increase in 20 metabolic equivalents of task-minute/day [METs-min/day]) with drug initiation were studied by multivariable Cox regressions (covariates: age, sex, PREDIMED intervention group, recruitment site, education, smoking habit, BMI, alcohol, and energy intake; multiple comparisons: Bonferroni method). We explored non-linear exposure-outcome associations using smoothed cubic splines and the interaction among both exposures.
Results One-point increases in MedDiet adherence score were associated with 23-28% less initiation of antidepressants (hazard ratio [HR] 0.72, 95% confidence interval [CI] 0.67-0.77), anxiolytics (HR 0.75, 95%CI 0.70-0.81), antipsychotics (HR 0.77, 95%CI 0.65-0.91), and antiseizure drugs (HR 0.77, 95%CI 0.69-0.85). Associations for anxiolytics and antiseizure drugs were particularly strong among participants with poor MedDiet adherence. Relationships between LTPA and initiation of antidepressant and anxiolytic drug use were non-linear. Among participants with the lowest LTPA values (0-150 METs-min/day), 20 METs-min/day increases were associated with 20% less risk of initiating antidepressant use (HR 0.80, 95%CI 0.75-0.86) and 15% less risk of initiating anxiolytic medication (HR 0.85, 95%CI 0.79-0.90). 20 METs-min/day increases were linearly associated with less initiation of antiseizure drugs (HR 0.96, 95%CI 0.94-0.99), and no clear associations were found for antipsychotic drugs. Individuals with high MedDiet adherence (≥10 adherence points) and high LTPA levels (≥150 METs-min/day) showed 42-59% less risk of initiating psychoactive drugs (antidepressants: HR 0.41, 95%CI 0.30-0.56; anxiolytics: HR 0.54, 95%CI 0.41-0.71; antipsychotics: HR 0.45, 95%CI 0.21-0.95; antiseizure drugs: HR 0.58, 95%CI 0.37-0.90). The combination was additive for antidepressants, antipsychotics and antiseizure drugs and synergistic for anxiolytics (p-interaction = 0.076).
Conclusions Sustained adherence to MedDiet and LTPA were linked to lower initiation of psychoactive drugs in older adults.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Blanquerna School of Health Sciences (University Ramon Llull, Barcelona, Spain) and the Instituto de Salud Carlos III [grant number CD17/00122]. The funders had no role in the study design; the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The views and opinions expressed in this paper are those of the authors only and do not necessarily reflect those of the funders.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol of the PREDIMED study complied with the Declaration of Helsinki for Medical Research involving Human Subjects. It received approval from institutional ethic committees at all recruitment sites. The protocol of this sub-study received approval from the Hospital del Mar Ethics Committee (Barcelona, Spain). The PREDIMED study protocol was registered with the International Standard Randomized Controlled Trial Number ISRCTN35739639 (http://www.isrctn.com/ISRCTN35739639) and is available in the PREDIMED study website (http://www.predimed.es). All participants provided written informed consent before joining the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The dataset analyzed during the current study cannot be made publicly available due to national data regulations and ethical considerations, including the absence of explicit written consent from study participants to make their deidentified data available upon study completion. However, data described in the manuscript will be provided to bona fide investigators for collaboration upon request and approval. Requests can be made by sending a letter to the PREDIMED Steering Committee (predimed-steering-committee{at}googlegroups.com).
ABBREVIATIONS
- HR
- hazard ratio
- LTPA
- leisure-time physical activity
- MedDiet
- Mediterranean Diet
- METs-min/day
- metabolic equivalents of task per minute per day
- PREDIMED
- PREvención con DIeta MEDiterránea
